HTA of Advate in the treatment and
the prophylaxis of Hemophilia A: ethical
considerations

Maria Luisa Di Pietro

HTA of Advate in the treatment and the prophylaxis of Hemophilia A: ethical considerations

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Abstract

The safety, tolerability and efficacy both in terms of prophylaxis and of the therapy of bleeding episodes achievable with Advate® enables us to issue an overall favorable ethical judgment. It is nonetheless advisable that decision makers work towards the creation of procedures of continuity in treatment and towards global care for patients, as well as towards guaranteeing equal access to medicine for all patients.

Lingua originale	English
pagine (da-a)	97-102
Numero di pagine	6
Rivista	Italian Journal of Public Health
Volume	9
Stato di pubblicazione	Pubblicato - 2012

Keywords

Advate
ethical considerations in HTA

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'HTA of Advate in the treatment and the prophylaxis of Hemophilia A: ethical considerations'. Insieme formano una fingerprint unica.

Cita questo

@article{4b805806d6df4c4f95588fd78c355855,

title = "HTA of Advate in the treatment and the prophylaxis of Hemophilia A: ethical considerations",

abstract = "The safety, tolerability and efficacy both in terms of prophylaxis and of the therapy of bleeding episodes achievable with Advate{\textregistered} enables us to issue an overall favorable ethical judgment. It is nonetheless advisable that decision makers work towards the creation of procedures of continuity in treatment and towards global care for patients, as well as towards guaranteeing equal access to medicine for all patients.",

keywords = "Advate, ethical considerations in HTA, Advate, ethical considerations in HTA",

author = "{Di Pietro}, {Maria Luisa}",

year = "2012",

language = "English",

volume = "9",

pages = "97--102",

journal = "Epidemiology Biostatistics and Public Health",

issn = "2282-2305",

publisher = "Milano : PREX",

}

TY - JOUR

T1 - HTA of Advate in the treatment and the prophylaxis of Hemophilia A: ethical considerations

AU - Di Pietro, Maria Luisa

PY - 2012

Y1 - 2012

N2 - The safety, tolerability and efficacy both in terms of prophylaxis and of the therapy of bleeding episodes achievable with Advate® enables us to issue an overall favorable ethical judgment. It is nonetheless advisable that decision makers work towards the creation of procedures of continuity in treatment and towards global care for patients, as well as towards guaranteeing equal access to medicine for all patients.

AB - The safety, tolerability and efficacy both in terms of prophylaxis and of the therapy of bleeding episodes achievable with Advate® enables us to issue an overall favorable ethical judgment. It is nonetheless advisable that decision makers work towards the creation of procedures of continuity in treatment and towards global care for patients, as well as towards guaranteeing equal access to medicine for all patients.

KW - Advate

KW - ethical considerations in HTA

KW - Advate

KW - ethical considerations in HTA

UR - http://hdl.handle.net/10807/40096

M3 - Article

VL - 9

SP - 97

EP - 102

JO - Epidemiology Biostatistics and Public Health

JF - Epidemiology Biostatistics and Public Health

SN - 2282-2305

ER -